SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR.Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction.Am J Cardiol2004;93:198200.
  • 2
    Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al.Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.Circulation2003;107:13037.
  • 3
    Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A.High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.Arthritis Rheum2001;44:273745.
  • 4
    Charles-Schoeman C, Watanabe J, Lee YY, Furst DE, Amjadi S, Elashoff D, et al.Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.Arthritis Rheum2009;60:28709.
  • 5
    Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Ranganath VK, et al.Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.Ann Rheum Dis2012;71:115762.
  • 6
    Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, et al.Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.J Lipid Res2000;41:1495508.
  • 7
    Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, et al.Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.J Lipid Res2000;41:148194.
  • 8
    Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, et al.Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio [published erratum appears in J Clin Invest 1997;99:3043].J Clin Invest1997;99:200519.
  • 9
    Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, et al.Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.J Clin Invest1995;95:77482.
  • 10
    Mackness MI, Arrol S, Durrington PN.Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein.FEBS Lett1991;286:1524.
  • 11
    Durrington PN, Mackness B, Mackness MI.Paraoxonase and atherosclerosis.Arterioscler Thromb Vasc Biol2001;21:47380.
  • 12
    Costa LG, Cole TB, Jarvik GP, Furlong CE.Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism.Annu Rev Med2003;54:37192.
  • 13
    Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al.Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.JAMA2008;299:126576.
  • 14
    Costa LG, Vitalone A, Cole TB, Furlong CE.Modulation of paraoxonase (PON1) activity.Biochem Pharmacol2005;69:54150.
  • 15
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum1988;31:31524.
  • 16
    Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL.Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.Arthritis Rheum1995;38:448.
  • 17
    Fries JF, Spitz P, Kraines RG, Holman HR.Measurement of patient outcome in arthritis.Arthritis Rheum1980;23:13745.
  • 18
    Bild DE, Detrano R, Peterson D, Guerci A, Liu K, Shahar E, et al.Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).Circulation2005;111:131320.
  • 19
    Charles-Schoeman C, Khanna D, Furst DE, McMahon M, Reddy ST, Fogelman AM, et al.Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.J Rheumatol2007;34:145964.
  • 20
    Rader DJ.Molecular regulation of HDL metabolism and function: implications for novel therapies.J Clin Invest2006;116:3090100.
  • 21
    Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, et al, for the ILLUMINATE Investigators.Effects of torcetrapib in patients at high risk for coronary events.N Engl J Med2007;357:210922.
  • 22
    Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, et al, for the dal-OUTCOMES Investigators.Effects of dalcetrapib in patients with a recent acute coronary syndrome.N Engl J Med2012;367:208999.
  • 23
    Aubry MC, Maradit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE.Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis.J Rheumatol2007;34:93742.
  • 24
    Isik A, Koca SS, Ustundag B, Celik H, Yildirim A.Paraoxonase and arylesterase levels in rheumatoid arthritis.Clin Rheumatol2007;26:3428.
  • 25
    Tanimoto N, Kumon Y, Suehiro T, Ohkubo S, Ikeda Y, Nishiya K, et al.Serum paraoxonase activity decreases in rheumatoid arthritis.Life Sci2003;72:287785.
  • 26
    Popa C, van Tits LJ, Barrera P, Lemmers HL, van den Hoogen FH, van Riel PL, et al.Anti-inflammatory therapy with tumour necrosis factor α inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.Ann Rheum Dis2009;68:86872.
  • 27
    Elfasakhany F, Mona M, Hussein M, Beyari M, Abou-Elnoeman S.Paraoxonase 1 (PON1) Glu 192 Arg gene polymorphism and serum paraoxonase activity in rheumatoid arthritis among Egyptians.Tanta Med Sc J2010;5:10311.
  • 28
    Evans MR, Escalante A, Battafarano DF, Freeman GL, O'Leary DH, del Rincon I.Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis.Arthritis Rheum2011;63:121120.
  • 29
    Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L, et al.Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.J Rheumatol2008;35:398406.
  • 30
    Watanabe J, Charles-Schoeman C, Miao Y, Elashoff D, Lee YY, Katselis G, et al.Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis.Arthritis Rheum2012;64:182837.